Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Cough, cold and allergy (hay fever) remedies are widely consumed consumer health items in the Guatemalan market. These products have established broad distribution throughout the country, with products available throughout the modern and traditional…
Analgesics is expected to register moderate constant value growth in 2023. Though there was widespread severe flu in early 2023, cough and cold remedies are not expected to benefit to a huge degree, as most of these patients were hospitalised or put…
The harsh climatic conditions in Kuwait with extreme heat, rising pollution and large amounts of dust continue to play a key role in driving demand across key OTC categories, in particular analgesics and cough, cold and allergy (hay fever) remedies.…
In general, consumer health in Kazakhstan is performing well towards the end of the review period. However, high inflation, increases in the costs of raw materials for the production of medicines and changed or disrupted logistics/supply routes have…
Consumer health in Honduras experienced a year of growth in value terms in 2023 that was in line with the country's inflation. Categories such as analgesics, cough, cold and allergy (hay fever) remedies, dermatologicals, and sports nutrition…
Consumer health has seen demand dampened by consumers being confronted with very high inflation. The rate of 9.2% in 2022 was the highest experienced in decades. As a result, more consumers have been forced to prioritise household spending on…
Consumer health is expected to register moderate constant value growth in 2023. Continuing economic uncertainty as a result of Russia’s invasion of Ukraine and high inflation is continuing to have an effect and consumers are expected to be highly…
In 2023, Cambodia seems to have recovered from the COVID-19 pandemic. Meanwhile, consumer health demand is rising due to modernisation, urbanisation, and health risks from harmful chemicals. Nonetheless, challenges still exist, such as external…
Analgesics is projected to continue to post fast retail volume growth over 2023. The potential for even higher growth is restricted by many households retaining stocks of analgesics purchased during the Coronavirus (COVID-19) pandemic. One clear…
Analgesics is set to see a decline in sales in 2023 as consumers have migrated away from aspirin in an uncertain economic environment and sought to prioritise household essentials, while turning to other categories to treat basic ailments such as…